Search research articles
Contact Us
Filters
Showing results (111-120 of 158) with videos related to
Page
of 16
Sort By:
Operative Neurosurgery (Hagerstown, Md.)
|
January 14, 2025
Planned Surgical Trajectory Affects Clinical Motor Outcome in Deep Brain Stimulation Targeted at Subthalamic Nucleus for Parkinson's Disease
Laura S Wang, John R Younce, Mikhail Milchenko, et al.
Neurology
|
September 25, 2003
Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD
T Hershey, F J Revilla, A R Wernle, et al.
Pharmacogenetics
|
October 30, 2003
Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors
Mary F Hebert, Amy L Dowling, Cynthia Gierwatowski, et al.
Journal of Cognitive Neuroscience
|
January 19, 2002
Wada testing reveals frontal lateralization for the memorization of words and faces
W M Kelley, J G Ojemann, R D Wetzel, et al.
Journal of Protein Chemistry
|
February 24, 2001
Steady-state kinetic analysis of human ubiquitin-activating enzyme (E1) using a fluorescently labeled ubiquitin substrate
K E Wee, Z Lai, K R Auger, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Heteroatom- and carbon-linked biphenyl analogs of Brequinar as immunosuppressive agents
D G Batt, J J Petraitis, S R Sherk, et al.
Epilepsia
|
August 5, 2017
Postoperative seizure freedom does not normalize altered connectivity in temporal lobe epilepsy
Luigi Maccotta, Mayra A Lopez, Babatunde Adeyemo, et al.
Neurosurgery
|
October 3, 2007
Safety and efficacy of subthalamic nucleus deep brain stimulation performed with limited intraoperative mapping for treatment of Parkinson's disease
Samer D Tabbal, Fredy J Revilla, Jonathan W Mink, et al.
Mediators of Inflammation
|
January 1, 1993
IL-1 and its role in rat carrageenan pleurisy
R Goodman, L R Mantegna, C L McAilister, et al.
Molecular Cancer Therapeutics
|
August 13, 2009
The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
M Cecilia Crisanti, Africa F Wallace, Veena Kapoor, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 158) with videos related to
Sort By:
Page
of 16
Operative Neurosurgery (Hagerstown, Md.)
|
January 14, 2025
Planned Surgical Trajectory Affects Clinical Motor Outcome in Deep Brain Stimulation Targeted at Subthalamic Nucleus for Parkinson's Disease
Laura S Wang, John R Younce, Mikhail Milchenko, et al.
Neurology
|
September 25, 2003
Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD
T Hershey, F J Revilla, A R Wernle, et al.
Pharmacogenetics
|
October 30, 2003
Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors
Mary F Hebert, Amy L Dowling, Cynthia Gierwatowski, et al.
Journal of Cognitive Neuroscience
|
January 19, 2002
Wada testing reveals frontal lateralization for the memorization of words and faces
W M Kelley, J G Ojemann, R D Wetzel, et al.
Journal of Protein Chemistry
|
February 24, 2001
Steady-state kinetic analysis of human ubiquitin-activating enzyme (E1) using a fluorescently labeled ubiquitin substrate
K E Wee, Z Lai, K R Auger, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Heteroatom- and carbon-linked biphenyl analogs of Brequinar as immunosuppressive agents
D G Batt, J J Petraitis, S R Sherk, et al.
Epilepsia
|
August 5, 2017
Postoperative seizure freedom does not normalize altered connectivity in temporal lobe epilepsy
Luigi Maccotta, Mayra A Lopez, Babatunde Adeyemo, et al.
Neurosurgery
|
October 3, 2007
Safety and efficacy of subthalamic nucleus deep brain stimulation performed with limited intraoperative mapping for treatment of Parkinson's disease
Samer D Tabbal, Fredy J Revilla, Jonathan W Mink, et al.
Mediators of Inflammation
|
January 1, 1993
IL-1 and its role in rat carrageenan pleurisy
R Goodman, L R Mantegna, C L McAilister, et al.
Molecular Cancer Therapeutics
|
August 13, 2009
The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
M Cecilia Crisanti, Africa F Wallace, Veena Kapoor, et al.
Page
of 16